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Introduction: Presbycusis or age-related hearing loss (ARHL) is a ubiquitous health
problem. It is estimated that it will affect up to 1.5 billion people by 2025. In addition,
tinnitus occurs in a large majority of cases with presbycusis. Glutamate metabotropic
receptor 7 (GRM7) and N-acetyltransferase 2 (NAT2) are some of the genetic markers
for presbycusis.
Objectives: To explore patterns of hearing loss and the role of GRM7 and NAT2 as
possible markers of presbycusis and tinnitus in a Portuguese population sample.
Materials and Methods: Tonal and speech audiometry, tinnitus assessment, clinical
interview, and DNA samples were obtained from patients aged from 55 to 75 with
or without tinnitus. GRM7 analysis was performed by qPCR. Genotyping of single
nucleotide polymorphisms (SNPs) in NAT2 was performed by PCR amplification
followed by Sanger sequencing or by qPCR.
Results: We screened samples from 78 individuals (33 men and 45 women). T allele
at GRM7 gene was the most observed (60.3% T/T and 33.3% A/T). Individuals with a
T/T genotype have a higher risk for ARHL and 33% lower risk for tinnitus, compared
to individuals with A/A and A/T genotype, respectively. Being a slow acetylator (53%)
was the most common NAT2 phenotype, more common in men (55.8%). Intermediate
acetylator was the second most common phenotype (35.9%) also more frequent in
men (82.6%). Noise exposed individuals and individuals with ‘high frequency’ hearing
loss seem to have a higher risk for tinnitus. Our data suggests that allele AT of GRM7
can have a statistically significant influence toward the severity of tinnitus.
Conclusion: For each increasing year of age the chance of HL increases by 9%. The
risk for ARHL was not significantly associated with GRM7 neither NAT2. However, we
cannot conclude from our data whether the presence of T allele at GRM7 increases the
odds for ARHL or whether the A allele has a protective effect. Genotype A/T at GRM7
could potentially be considered a biomarker of tinnitus severity. This is the first study
evaluating the effect of GRM7 and NAT2 gene in tinnitus.
Keywords: presbycusis, GRM7, NAT2, tinnitus, markers, comorbidities
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INTRODUCTION
Presbycusis [age-related hearing loss (ARHL)] is a universal
feature of mammalian aging in which the auditory function
is compromised, hearing thresholds increase, and frequency
resolution gets poorer. As a result, in noisy environments speech-
understanding deteriorates and temporal processing deficits
in gap detection measures increase (Lee, 2013). In humans,
this condition affects tens of millions of people world-wide
(Yamasoba et al., 2013). Many people with hearing loss also
experience tinnitus, which is the perception of a sound in one
or both ears or in the head in the absence of an external sound
source (Jastreboff and Hazell, 1993).
Presbycusis is complex in that it has repercussions at a
physical, cognitive, emotional, and social level; quality of life
can deteriorate, and for some people presbycusis could lead
to depression, social isolation and lower self-esteem (Lee,
2013; Ciorba et al., 2015). Environmental factors such as
diet, physical exercise, smoking, and intake of medications
are some of the extrinsic factors predisposing to presbycusis.
There are several auditory structures affected by presbycusis,
such as hair cells, stria vascularis, afferent spiral ganglion
neurons and the central auditory pathways (Fuentes-Santamaría
et al., 2013). Based on results of audiometric tests and
temporal bone pathology, Schuknecht and Gacek (1993) and
later modified by Nelson and Hinojosa (2003), classified
presbycusis as either sensory (downslope audiometry and
cochlear degeneration), neural (downslope audiometry and
very poor speech discrimination, spiral ganglion and nerve
fibers degeneration), metabolic (audiometry in a platform and
strial atrophy), cochlear conductive (downslope audiometry and
thickening and stiffening of basilar membrane), mixed (mixture
of the above), or undetermined (none of the above) types.
Depending on the type and severity of the hearing loss,
several options are available to reduce the hearing difficulties
and consequently improve quality of life. When patients are
appropriately fitted and motivated, hearing aids and cochlear
implants (CIs) are the most commonly used devices for treating
mild-severe presbycusis. Electric-acoustic stimulation and active
middle ear implants may also be suitable solutions for treating
presbycusis (Sprinzl and Riechelmann, 2010).
Biological markers are widely used in oncology, hematology
and in other medical disciplines to diagnose or to monitor various
diseases. In otology, biological markers are not yet widely used,
but once identified, they could provide a means of determining
the time-course or most effective treatment for an individual
with presbycusis or tinnitus. Potential biomarkers include
mutations in mitochondrial DNA, chromosomal mutations,
state of chronic inflammation, presence of certain diseases
associated with earlier onset or progression of presbycusis (e.g.,
diabetes, hypertension) and metabolic diseases (Van Eyken et al.,
2007; Verschuur et al., 2014). It was recently estimated that
35–55% of auditory aging could have a genetic background
(Ruan et al., 2014). Of interest are genes coding for glutamate
receptors as glutamate is the main excitatory neurotransmitter
in the peripheral and central auditory pathways. It has been
suggested that increased release of glutamate may be involved
in the auditory aging and the generation and maintenance of
tinnitus by causing “excitotoxicity.” There are many types of
glutamate receptors, such as N-methyl-D-aspartate (NMDA) and
alfa-amine propionic acid (AMPA), the latter being the most
relevant receptor in physiological neurotransmission at auditory
pathways. NMDA receptors are not essential for the auditory
transmission, but they have been shown to be expressed in
the cochlea after induction of tinnitus. Moreover, it has been
demonstrated that the application of NMDA antagonists directly
into the cochlear fluid can block salicylate-induced tinnitus in
animals (Figueiredo et al., 2008).
GRM7 encodes a metabotropic glutamate receptor subtype
7 (mGluR7), a G protein-coupled receptor regulating auditory
nerve excitability. When bound by L-glutamate, mGluR7changes
the configuration of adenylyl cyclase, which has implications
in the metabolism of AMPc, control of cellular cycle, and
normal functioning of central nervous pathways. mGluR7 plays
a general role in glutamate synaptic transmission (Voytenko and
Galazyuk, 2011). In the auditory periphery, mGluR7 is thought
to mediate glutamate excitotoxicity (Pujol et al., 1993) and in the
cochlea mGluR7 maintains the glutamate-dependent equilibrium
between the inner hair cells and the spiral ganglion neurons
(Newman et al., 2012). Its role in the higher auditory pathways
remains unclear (Lu, 2014). Single nucleotide polymorphisms
(SNPs) of GRM7 have been demonstrated to be associated
with auditory aging in European (Friedman et al., 2009) and
American populations (Newman et al., 2012) but not of a Chinese
population (Luo et al., 2013). Interestingly, Newman et al. (2012)
have reported that certain SNP variants of GRM7 associate with
poorer speech recognition in the elderly. The importance of
GRM7 in the auditory system is supported by the detection
of mGluR7 in the inner and outer hair cells and in the spiral
ganglion nerve (Friedman et al., 2009).
Highly concentrated glutamate may affect membrane
permeability in the hair cells, causing an increase in
Cl− influx, and consequently an osmotic imbalance and
membrane disruption (Puel et al., 1998). In addition, glutamate
excitotoxicity induces apoptotic cell death and inflammation
(Sahley et al., 2013). This was demonstrated in an animal model
to be directly responsible for the loss of inner hair cells in a
time-, dose- and tonotopy-dependent manner (Hu et al., 2015).
Interestingly, neonatal exposure to monosodium glutamate has
been shown to induce neuronal atrophy and dysmorphia in the
cochlear nucleus and in the superior olivary complex (Foran
et al., 2017). The physiological effects of glutamate excitotoxicity
therefore are concluded to include ARHL (Pujol et al., 1993) and
tinnitus (Brozoski et al., 2012; Sahley et al., 2013; Yu et al., 2016).
Oxidative stress represents an imbalance between the
production of reactive oxygen species (ROS) and their
detoxification and has been postulated to play a major role
in the overall aging process and to significantly contribute
to the ARHL. Oxidative stress in the inner ear, secondary
to impairments in defense mechanisms caused by certain
polymorphisms related to a battery of antioxidant systems, could
make individuals more susceptible to ARHL (Seidman et al.,
2002; Fujimoto and Yamasoba, 2014).
In the adult inner ear, presence of several detoxification and
antioxidant enzymes including catalase, superoxide dismutase,
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glutathione peroxidase, and glutathione S-transferases (GST) has
been demonstrated.
One of the sources leading to accumulation of ROS are
insufficiently acetylated drugs which accumulate and may
be converted into reactive drug metabolites by oxidative
enzymes. N-acetyltransferase (NAT) are enzymes responsible
for the detoxification of exogenic substrates via N-acetylation
or O-acetylation. In humans, the catalytic activity by NAT
isoenzymes NAT1 and NAT2 may be regulate by these substrate
concentration. Both isoenzymes are highly polymorphic and
catalyze many aromatic amines and hydrazine substances
important for the balance of the oxidative status. In addition,
NATs are known to be involved in the detoxification of harmful
xenobiotics (Vatsis and Weber, 1993; Hein, 2002; Ünal et al.,
2005b).
Variation in NAT2 alleles or haplotypes resulting from
combination of SNPs is responsible for the N-acetylation
polymorphism. Regarding the latter, rapid, intermediate, and
slow acetylator phenotypes have been demonstrated. These
phenotypes are associated with the rate of catalytic activity and
accordingly predispose toward drug toxicity (Rajasekaran et al.,
2011).
Because the individuals with the null genotype for NAT2
may be more susceptible to effects of environmental toxins and
oxidative free radical cellular damage, the presbycusis becomes
an ideal model for evaluation of gene-environmental interaction
(Ünal et al., 2005a,b). Although many individuals have been
exposed to several environmental risk factors, the ARHL develops
to a different degree in various age groups. This suggests genetic
host factor(s) contributing to the degenerative mechanisms (Ünal
et al., 2005b).
Previous studies demonstrated the association between
the common human NAT2 alleles and ARHL. Independent
studies have showed a significant association between NAT2
polymorphisms and presbycusis, namely NAT2∗6A in the
Turkish population (Ünal et al., 2005b) and in the European
population (Van Eyken et al., 2007) with Caucasian subjects
carrying a NAT∗6A mutant allele having an increased risk
to Presbycusis (Bared et al., 2010). Other studies considering
different NAT2 alleles reported negative associations with
ARHL (Dawes et al., 2015) and with the shape of the
audiograms (Angeli et al., 2012), when considering audiometric
patterns of presbycusis in older individuals. However, most
authors suggested that NAT2 gene is a susceptibility factor for
development of hearing impairment (Ünal et al., 2005b; Dawes
et al., 2015).
Here we explore the relationships between presbycusis,
tinnitus, co-morbidities, and the genotypes of GRM7 and NAT2,
in a sample of older Portuguese adults.
PATIENTS AND METHODS
Subjects
Inclusion criteria was the presence of sensory presbycusis, with
or without tinnitus, in adults of any gender, aged between 55 and
75 years, from the Portuguese population.
Our sample included 78 older individuals (n = 45 women,
n= 33 men).
For the purposes of inclusion presbycusis was defined
as bilateral sensorineural deafness in downslope audiometric
pattern, above 1000 Hz with poor speech discrimination
(discrimination threshold > 40 dB SPL and 100% discrimination
to 60 dB or worse). Although all included participants
have presbycusis we will consider a subgroup with normal
hearing because the adopted classification uses conversational
frequencies.
Exclusion criteria were considered: inability to understand
and sign the informed consent due to a significant cognitive
impairment, an uncompensated medical disorder that requires
urgent evaluation or if the individual has a serious psychiatric
disorder. Also individuals over 55 years who presented possible
factors that may overlap the variables under study were excluded
[e.g., Ménière’s disease, chronic otitis media, otosclerosis, tinnitus
from disease of the outer ear (occlusive exostosis, outer otitis)],
history of ototoxic drugs use, massive noise exposure, a history of
previous malignancy with chemotherapy, history of autoimmune
disorders and neurodegenerative and demyelinating diseases.
This study had the approval of the Ethical Committees
from Hospital Cuf Infante Santo (November 26th, 2014),
Nova Medical School (n◦65/2014/CEFCM) and the National
Department of Personal Data Protection (authorization
number:1637/2016).
Accordingly we obtained the Institutional Scientific Review
Board approval of the process for taking informed consent and
overall study design. The study was conducted in accordance with
the Declaration of Helsinki.
Clinical Evaluation
Written informed consent, clinical and familial history,
audiological evaluation and a blood sample, using Whatman R©
FTA R© card technology, was obtained from every subject.
A questionnaire concerning epidemiologic data
(demographic, previous and present diseases, toxicological
habits and noise exposure) was completed by the researcher
through participant interview.
Audiological Assessment
Hearing thresholds were determined by pure tone audiometry
(air and bone) according to ISO 8253 and 389. The exam was
performed in a soundproof booth using an Interacoustics R©,
Assens, Denmark audiometer (Model: AC40, Serial No.: 98 019
046) and TDH39 headphones fitted with noise-excluding headset
ME70 and bone conductor B-71. Audiometry was performed at
frequencies from 0.25 to 16 kHz (standard tonal audiometry and
extended high frequency). The category of Hearing Loss (HL) was
defined according to the average threshold across 500, 1000, 2000,
and 4000 Hz in the better ear as mild (21–40 dB), moderate (41–
70 dB), severe (71–95 dB) or profound (>95 dB), from an average
of thresholds at 500, 1000, 2000, and 4000 Hz in the better ear,
according to the European Working Group Genetics of Hearing
Impairment (After Liu and Xu, 1994; Parving and Newton, 1995).
Speech audiometry evaluation was obtained with headphones
(using mp3 player), or in open field, where the evaluator was
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hiding his lips to prevent lip-reading. The number of disyllables
that patient repeats correctly was recorded. This intelligibility
threshold for two-syllable words intends to measure hearing
sensitivity threshold through the intensity level identification
in which the patient can correctly identify 50% or more of a
disyllables list. On the other hand, the speech discrimination
evaluates the lowest intensity level at which a listener can
understand speech.
Tinnitus Assessment
Psychoacoustic assessment consisted of loudness match, pitch
match, minimum masking level (MML) or Feldmann masking
curves, residual inhibition, and loudness discomfort levels (LDL).
The severity of tinnitus was evaluated using the Tinnitus
Handicap Inventory (THI; Newman et al., 1996). THI comprises
25 questions concerning tinnitus, and the response options are
“Yes,” “Sometimes,” and “No,” respectively, corresponds to 4,
2, and 0, accounting for a total score that may vary between
0 and 100. The questionnaire comprehends three sub-scales or
dimensions: Functional (11 items – contributing 0–44 for the
final score), Emotional (9 items – contributing 0–36 for the final
score) and Catastrophic (5 items – contributing 0–20 for the final
score). This allow to verify which are the most affected aspects
and accordingly choose the therapeutic interventions. The total
score of the responses allows tinnitus classification according to
its severity or impact in daily life – 0–16: Slight or no handicap
(Grade 1), 18–36: Mild handicap (Grade 2), 38–56: Moderate
handicap (Grade 3), 58–76: Severe handicap (Grade 4), 78–100:
Catastrophic handicap (Grade 5).
Additionally THI is a self-administered instrument, easy
to quote, to interpret and has good psychometrics properties
(McCombe et al., 2001).
Genetic Analysis
Total genomic DNA was extracted from a blood sample on
FTA cards using a commercial NZY Tissue gDNA Isolation
Kit (NZYTech, Lisbon, Portugal), strictly according to the
manufacturer’s instructions. Molecular analysis of GRM7 gene
was assessed by qPCR for A/A, A/T, and T/T genotypes, at
rs11928865 SNP. Concerning NAT2 gene, rs1041983, rs1801280,
rs1799929, rs1799930, rs108 and s1799931 were assessed by qPCR
or by bidirectional sequencing of the target region in order to
identify all the SNPs.
Statistical Analysis
We conducted a descriptive analysis for variables such as gender
and age. The audiograms were analyzed considering the best
ear (estimated based on the lowest average of frequencies of
0.5–4 kHz). We also evaluated the “high frequency” pure-tone
average (PTA) at 2, 4, and 8 kHz (Newman et al., 2012). Chi-
square Test or Fisher Exact Test for general association between
two variables were used. Mann–Whitney or Kruskal–Wallis
(for more than two groups) tests were employed to compare
hearing thresholds. A Dunn’s test with a Bonferroni correction
was applied for multiple pairwise comparisons. The level of
significance considered was p= 0.05.
All the results were analyzed through logistic regression
model, where age and gender where considered as control for all
other variables.
RESULTS
Participants in our study were 78 older adults aged
64.6 ± 5.58 years old (range = 55–75 years old). Most
participants were female (n = 45, 57.7%), presenting an average
age of 64.1 ± 5.35 years old. For men (n = 33, 42.3%), the mean
age was 65.3± 5.89 years old (Table 1).
Hearing Thresholds
The average hearing threshold values (by gender and age) are
shown in Figure 1. There were significant differences between
the gender groups regarding average and median values of
hearing thresholds at the frequencies of 4 kHz (p-value = 0.007)
and 8 kHz (p = 0.031) when comparing male and female
(Figure 1). There were significant differences between age groups
regarding the average and median values of hearing thresholds
at frequencies of 4 kHz (p = 0.003), 8 kHz (p < 0.001), 10 kHz
(p< 0.001) and 12 kHz (p< 0.001) when comparing the different
age groups (Figure 1).
When comparing hearing thresholds between the different
age groups, we found significant differences in females at
4 kHz (p = 0.009), 8 kHz (p = 0.011), 10 kHz (p = 0.018)
and 12 kHz (p = 0.002) (Figure 2). For males statistically
significant differences were observed between age groups at 8 kHz
(p = 0.009), 10 kHz (p = 0.003) and 12 kHz (p = 0.004)
(Figure 2).
According to age and gender grouping and comparing males
to females we found significant differences for hearing thresholds
for the age group 55–60 years old for 1 kHz frequency (p= 0.022)
and 4 kHz frequency (p= 0.028) (Figure 2).
Distribution of the individuals according to the hearing loss
and tinnitus presence (Table 1) shows that in subgroup 1,
18 (23.1%) individuals who had normal hearing thresholds at
speech frequencies (0.5–4 kHz) but not tinnitus; subgroup 2, 23
(29.5%) individuals who had normal hearing thresholds at speech
frequencies and tinnitus; subgroup 3, 10 (12.8%) individuals who
had hearing loss but not tinnitus; and subgroup 4, 27 (34.6%)
individuals who had hearing loss and tinnitus (see also Figure 3).
There are no statistical differences in age or gender between those
four subgroups.
TABLE 1 | Distribution of the individuals by subgroups according to hearing loss,
tinnitus presence (PTA = Pure Tone Average) and gender.
Subgroup Audiological characteristic Gender n
Male Female
1 PTA ≤ 20 without Tinnitus 5 13 18 (28%)
2 PTA ≤ 20 with Tinnitus 8 15 23 (29.5%)
3 PTA ≥ 20 without Tinnitus 6 4 10 (12.8%)
4 PTA ≥ 20 with Tinnitus 14 13 27 (34.6%)
Total 33 45 78
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FIGURE 1 | Tonal audiogram curves showing differences between: (A) gender and (B) age intervals, for all the frequencies used to estimate HL status.
FIGURE 2 | (A) Female and (B) Male hearing thresholds between the different aging groups.
FIGURE 3 | Hearing thresholds between subgroups.
We found statistically relevant differences between the four
described groups which corroborates the logical of having chosen
this subdivision of our study population. (p < 0.001 at the
majority of frequencies).
There were significant differences in speech audiograms (PTA,
speech recognition threshold [SRT], 100%; p-value = <0.001;
<0.001; <0.001, respectively) between subgroups, either for the
right ear or for the left ear. The differences were found between
subgroups 4 or 3 and the subgroups 1 and 2 for PTA (0%), SRT
(50%) and (100%) (Figure 4).
Because our study population represents older adult
individuals with sensory presbycusis we evaluated the “high
frequency” pure-tone average (PTA) at 2, 4, and 8 kHz. We
compared the groups of individuals with and without tinnitus
and the four subgroups (Table 1). In respect to having or not
tinnitus we found statistical differences between those groups
(p = 0.003) (for more details see Appendix 1). We found
statistically significant differences (p < 0.001) when comparing
the four subgroups described in Table 1 (for more details see
Appendix 2).
Characterization of the considered comorbidities in
our sample are presented in Table 2. Concerning hearing
thresholds according to presence or not of the studied
comorbidities, we found the following relevant significant
differences: from 0.5 to 4 kHz for cholesterol; at 4 kHz for
measles.
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FIGURE 4 | Speech audiograms between subgroups.
When comparing the group of participants with and
without tinnitus the most statistical relevant results were
concerning ‘high frequency’ hearing loss and noise exposure.
In our study population, 50 individuals (64.1%) had
tinnitus.
We have determined the distribution of studied comorbidities
in our tinnitus population (Figure 5). The most prevalent were
measles, hypercholesterolemia, noise exposure, mumps, smoking
and hypertension, in a descendent order of frequency.
In our sample, 49 participants (62.8%) reported to have
high blood values of cholesterol. Of those, 27 individuals
(55.1%) were taking medication (statins) (Appendix 3). There
was a significant association between tinnitus and statins
intake in those individuals reporting hypercholesterolemia
(ÔR = 0.28, p = 0.045, CI = 0.08− 0.99) (Table 3). We found
no relevant association between statins intake and hearing
loss.
TABLE 2 | Distribution of the most common comorbidities in the individual of the
sample.
Comorbidities n
Absent Present
Cholesterol 29 (37.2%) 49 (62.8%)
Hypertension 43 (55.1%) 35 (44.9%)
Cardiovascular disease 73 (93.6%) 5 (6.4%)
Tinnitus 28 (35.8%) 50 (64.1%)
Diabetes 65 (83.3%) 13 (16.7%)
Thyroid problems 70 (89.7%) 8 (10.3%)
Smoking habits 44 (56.4%) 34 (43.6%)
Meningitis 77 (98.7%) 1 (1.3%)
Mumps 44 (56.4%) 34 (43.6%)
Measles 21 (26.9%) 57 (73.1%)
Tuberculosis 75 (96.2%) 3 (3.8%)
Ear diseases 62 (79.5%) 16 (20.5%)
Ear surgery 76 (97.4%) 2 (2.6%)
Noise exposure 51 (65.4%) 27 (34.6%)
Hormonal therapy 55 (70.5%) 23 (29.5%)
Ototoxic medication 58 (74.4%) 20 (25.6%)
FIGURE 5 | Distribution of the most common comorbidities in the individuals
with tinnitus.
Tinnitus Evaluation
Subgroups 2 and 4 included participants with tinnitus.
Concerning tinnitus laterality, 33 of them reported to have
a unilateral tinnitus (12 on the right ear and 21 on the left ear)
and 17 participants have a bilateral tinnitus. According to THI
score (Figure 6) for most participants tinnitus was bothersome,
only 10 subjects had a slight handicap.
Modeling the data
All the results were analyzed through a logistic regression model
age and gender were considered in all the models with the
objective of controlling eventual confounding since these two
factors are known to be related to hearing loss.
The regression logistic model was applied to HL considering
female as reference (for more details see Appendix 4). The odds
of developing presbycusis was significantly higher for males than
for females (ÔR = 2.9, p = 0.032). When considering age as a
covariate, the effect was slight but significant, being the odds of
having hearing loss 9% higher for each increasing year (ÔR =
1.09, p = 0.03).
Using this statistical model for all the comorbidities
considered and controlled for age the odds of having hearing
loss was significantly lower for subjects with high cholesterol
(ÔR = 0.33, p = 0.034).
We found no association between HL and high blood pressure
or noise exposure.
In addition, using the regression logistic model for tinnitus
considering men and the absence of tinnitus as reference, we
found that noise exposure seems to influence the occurrence
of tinnitus (ÔR = 3.65, p = 0.026, CI = 1.2− 11.4), when
considered isolated. This result is statistically very relevant.
There were no other statistically significant results concerning
other comorbidities in this study (for more details see
Appendix 5).
GRM7 and NAT2 genes
Results for GRM7 gene at rs11928865 SNP refers to A or T
alleles and contribute for three possible genotypes: A/A, A/T,
or T/T. GRM7 data are presented comparatively (Table 4) with
data for Iberian Peninsula and Europe in order to compare our
population with others.
Frontiers in Aging Neuroscience | www.frontiersin.org 6 November 2017 | Volume 9 | Article 346
fnagi-09-00346 October 31, 2017 Time: 16:14 # 7
Haider et al. Tinnitus Biomarkers in a Older Population
TABLE 3 | Association between tinnitus and statins intake in individuals reporting
hypercholesterolemia.
Statins
intake
Without
Statins
ÔR p-value (fisher
test)
95% IC
Tinnitus 13 17 0.28 p = 0.045 [0.08 – 0.99]
Without tinnitus 14 5
∗p-value < 0.05.
FIGURE 6 | Distribution of the individuals according to THI.
Some genetic specificity has been reported for different
populations regarding deafness genes, and, interestingly,
genotypes representativeness for the individuals of our sample
were in accordance with values described in the European
population as well as in the Iberian population.
Analyzing these results and considering the hearing
thresholds, no significant differences were found in males
or females when the three genotypes were compared, however,
some differences in the pattern of the curves on the audiogram
can be seen.
Considering the Tinnitus Handicap Inventory scores (please
see Figure 6) the variable severe tinnitus (n= 12) joins the severe
and catastrophic grades. We found relevant statistical association
between the presence of GRM7 and severe tinnitus (individuals
having scored severe or catastrophic grade in THI). The results
are present in the Table 5.
We found no relevant statistical differences consideringGRM7
when comparing the four sub groups already described in
Table 1, evidencing no relation with this SNP and the presence
of presbycusis with or without tinnitus.
When considering genetic data, GRM7 genotype was
found not to be associated with the risk of developing
presbycusis (p = 0.889). However, the odds of HL is
TABLE 4 | Comparative results for rs11928865 SNP on GRM7 gene and
comparison with other populations.
Genotypes N Frequency Europe United Kingdom Iberian peninsula
A/A 5 0.064 0.087 0.055 0.065
A/T 26 0.333 0.382 0.473 0.393
T/T 47 0.603 0.531 0.473 0.542
Total 78 1 1 1 1
TABLE 5 | Association between THI score (tinnitus severity) and GRM7 gene.
GRM7 Severe tinnitus p-value Fisher test
A/A 1
A/T 7 0.0233∗ 0.0175
T/T 4
∗p-value < 0.05.
higher in individuals presenting A/T (29%) or T/T (2%)
genotype, than in A/A genotype. The same results were
observed when controlling for age and gender, however, in
this case the odds of HL in A/T genotype individuals was
nearly 39% higher than for A/A genotype individuals. The
odds of HL in T/T genotype was 15% higher than in A/A
genotype.
The relation between tinnitus and GRM7 gene was evaluated
considering two groups, one defined as “having an A allele”
(AA + AT) other defined as “not having an A allele” (TT).
Results were not significant (ÔR = 0.96) however, since the
estimated ÔR < 1, a decrease in the risk for tinnitus could
be thought. The GRM7 genotype was not identified as a risk
factor for tinnitus, neither when controlling for age (ÔR = 0.94)
(OR = 0.94) for gender (ÔR = 0.93) or both simultaneously
(ÔR = 0.93). Similar analysis was performed considering also
two groups but defined as “having a T allele” (TT and AT
genotypes). However, no significant association with tinnitus was
found.
Genetic analysis of NAT2 gene was performed in 65
individuals, 39 females (60%), and 26 males (40%). Rapid (R)
phenotype was least common (12.3%, n = 8), followed by
Intermediate (I) phenotype (35.4%, n = 23) and Slow (S)
phenotype (52.3%, n= 34) (please see Table 6).
The genotype 4/4 (considered as wild type) was observed in
9.1% (n = 6) of the individuals being the allele 4 present in
56.9% (n= 37) of the genotypes. The genotype 6A/6A previously
associated with presbycusis was found in 6.2% (n = 4) of the
individuals being the allele 6A present in 23.1% (n = 15) of the
individuals. The most common genotype is 5B/5B accounting for
50% (n = 11) of all the homozygous genotypes (33.9%, n = 22)
the sample (Kuznetsov et al., 2009).
We found no statistical differences in NAT2 gene expression
across our four subgroups described in Table 1, evidencing
no relation with the presence of presbycusis with or
TABLE 6 | Genotypes observed in the sample and their corresponding
phenotypes.
Genotype Phenotype
NAT2∗4/NAT2∗5U; NAT2∗6A/NAT2∗6A; NAT2∗5B/NAT2∗5D;
NAT2∗6J/NAT2∗13A; NAT2∗5A/NAT2∗5B; NAT2∗6N/NAT2∗6N;
NAT2∗6A/NAT2∗6B; NAT2∗5D/NAT2∗5G; NAT2∗5B/NAT2∗5B;
NAT2∗5R/NAT2∗12A; NAT2∗4/NAT2∗5J
S
NAT2∗4/NAT2∗4; NAT2∗12A/NAT2∗12C; NAT2∗4/NAT2∗12C R
NAT2∗4/NAT2∗5B; NAT2∗4/NAT2∗6A; NAT2∗4/NAT2∗5B;
NAT2∗4/NAT2∗5A; NAT2∗5B/NAT2∗12A; NAT2∗4/NAT2∗13A;
NAT2∗4/NAT2∗5V; NAT2∗6A/NAT2∗13A; NAT2∗5B/NAT2∗13A
I
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without tinnitus. No significant association with ARHL was
found, for the in the right and left ear or best or worst
ear.
Considering the Tinnitus Handicap Inventory scores, we
found significant association between severity of tinnitus
(grades severe and catastrophic from THI) and the presence
of NAT2 gene (please see more details in the next sub-
heading).
Modeling the Data – GRM7 and NAT2
All the results were analyzed through logistic regression model
(Tables 7, 8) where age, gender and noise exposure were
considered in the models with the purpose of controlling for
confounding. The independent variable in the model was severe
tinnitus (n= 12), (the sum of severe and catastrophic grades from
THI) (Figure 6).
We have considered the genotype T/T because after crossing
the GRM7 gene with the tinnitus population, we found that the
T/T genotype is more frequent and it is the most representative
so it was chosen as the reference category.
The odds of developing severe tinnitus was significantly
higher in the presence of genotype A/T when compared to
genotype T/T (ÔR = 14.2, p = 0.009, CI = 2.0− 97.8). When
considering the genotype A/A, no statistically significant
difference was found (ÔR = 2.9, p = 0.443, CI = 0.2− 42.2).
The probability of severe tinnitus among individuals with
genotype A/T is significantly higher when compared with
individuals with the genotype T/T (for more details see
Appendix 6).
When analyzing the presence of severe tinnitus through a
logistic regression model considering NAT2 as the independent
variable and controlling for age, gender and noise exposure,
the odds of developing severe tinnitus was significantly higher
in the presence of slow acetylator phenotype when compared
to intermediate acetylator (ÔR = 5.7, p = 0.095, CI = 1.5−
21.9). No statistically significant difference was found with
respect to rapid acetylator (ÔR = 2.8, p = 0.504, CI = 0.4−
20.8) (for more details see Appendix 7).
TABLE 7 | Logistic regression model in the GRM7 applied to severe tinnitus
considering the genotype T/T as reference.
Variable∗ ÔR p-value (Wald test) (95% IC)
GRM7
A/A 2.9 0.443 (0.2, 42.2)
A/T 14.2 0.009∗∗ (2.0, 97.8)
∗∗p-value < 0.05.
TABLE 8 | Logistic regression model in the NAT2 applied to severe tinnitus
considering intermediate acetylator as reference.
Variable∗ ÔR p-value (Wald test) (90% IC)
NAT2
Rapid acetylator 2.8 0.504 (0.4, 20.8)
Slow acetylator 5.7 0.095 (1.5, 21.9)
DISCUSSION
In the present research, we conducted a case history
questionnaire, hearing evaluation and gene screening analysis
for GRM7 and NAT2 in a sample of patients aged between 55 and
75 years, in an attempt to find factors that might contribute to
the diagnosis of presbycusis and tinnitus, which could be useful
for diagnosis and future therapeutic interventions.
Comorbidities Effect
Although in previous literature was described that individuals
with thyroid problems present increased hearing thresholds,
suggesting that thyroid hormones may act as regulators of the
auditory system (Forrest et al., 1996) our results do not show
any statistical relevance concerning this, one possible explanation
is the sample size. Only 10% of our participants report thyroid
problems which precludes statistical analysis.
Possibly for a similar reason our data doesn’t show that
individuals with high blood pressure may be at greater risk of
presbycusis than the normotensive. Hypertension has previously
been associated with increasing of the hearing threshold (Agarwal
et al., 2013, p. 614). Since both presbycusis and hypertension are
common and widespread disorders, the fact that hypertension
may influence presbycusis strongly suggests adding cardiologists
to the multidisciplinary team of professionals screening for
presbycusis and improving the quality of life of positively
identified individuals (Agarwal et al., 2013).
Our results found that hypercholesterolemic individuals had
a lower risk of HL, probably this is due to the fact that the
majority of them (67%) were having medication (statins) to
control cholesterol levels. These results are in accordance with
previous publications (Gopinath et al., 2011). In individuals with
hypercholesterolemia the chance of occurring tinnitus is 72%
lower in those who have statins intake. According to our results
It seems like the statins have a protector effect.
Noise exposure and “high frequency” hearing loss seems to
influence the occurrence of tinnitus, those were two of the most
statistical relevant findings in our study population, which is in
accordance with previous literature (Hoffman and Reed, 2004).
Gender and Age Effect
Significant differences on the HL degree were observed in
different frequencies for different age groups (Figure 2). Our
results show a significant age-dependent increase of hearing loss
in about 13% for both genders, although the risk of developing
presbycusis is about three times higher for men. This finding
is consistent with a previous reports (Pearson et al., 1995) but
contradicts another (Homans et al., 2016) where women were
found to have more hearing loss.
According to our data, the risk of presbycusis increases 9%
per year of life. Considering the increase in life expectancy of
the population in industrialized countries, our result presents
obvious consequences and must be considered for future clinical
management guidelines.
In our sample tinnitus was present in 60.7% of the participants
and men showed 53% more likelihood of developing tinnitus
than women. This contradicts other results (Vielsmeier et al.,
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2012) who reported higher tinnitus prevalence in women but in a
much younger population.
According to our data, and in agreement with previous
literature (Hoffman and Reed, 2004; Shargorodsky et al., 2010)
age is not associated with the risk of developing tinnitus.
GRM7 and NAT2 Effect
We did not find a significant relationship between GRM7
genotype and either presbycusis or tinnitus. Especially for men,
some differences concerning the pattern in the audiogram curves
were observed in relation to GRM7 phenotypes. For both
genders, the T allele in GRM7 gene is the most common allele
in our sample of older adults with presbycusis and tinnitus,
where genotypes A/T and T/T present higher level of hearing
loss compared to A/A genotype. Perhaps in a larger population
it could be demonstrated that the allele A of GRM7 plays a
protective role in presbycusis.
Hence, according to our results, GRM7 genotype does not
seem to be predictive of presbycusis since the odds to have
ARHL is not significant (p = 0.78). Corroborating our results,
Luo et al. (2013) studying an all-male population found that
the T-allele frequency was significantly different from the
genotype A/A+A/T comparing ARHL patients and healthy
controls and that the GRM7 SNP A > T was significantly
different between the two groups (Luo et al., 2013). On the
other hand, our findings differ from Friedman et al. (2009)
most likely due to sample size (Luo et al., 2013). Moreover,
the impact of the other variables – environmental, lifestyle,
noise exposure, cholesterol levels and stochastic element –
perhaps has prevailed over the genetic factor, declining
the importance between GRM7 gene and ARHL. Certainly
multicenter studies with higher sample sizes would overcome
these aspects.
Concerning NAT2 gene, Rapid (R) phenotype was the
least common, followed by the Intermediate (I) and Slow (S)
phenotypes.
We found relevant statistical association between the presence
of the allele A/T of GRM7 and severe tinnitus. The chance for
having a severe grade of tinnitus (severe or catastrophic grades in
THI) is 14,2 higher for those carrying the allele A/T compared to
T/T. Probably in larger scale studies could be demonstrated the
role of allele A/A that is the less frequent in our sample.
The odds of developing severe tinnitus was relatively higher
in the presence of slow acetylator phenotype of NAT2 when
compared to intermediate acetylator.
Our data suggests that allele A/T of GRM7 can have a
statistically significant influence toward the severity of tinnitus.
As well slow acetylator phenotype of NAT2 seems to have
a similar influence (not statistically relevant in our results).
Nevertheless, those results should be interpreted with caution
and future studies in larger scale are necessary to confirm this
correlation.
However, present data shows that genotype A/T and T/T
present, respectively, a 70 and 33.3% lower risk of developing
tinnitus, when compared to A/A genotype. No other studies were
found relating GRM7, NAT2 and tinnitus.
CONCLUSION
To the best of our knowledge, this is the first study on the
association between GRM7 and NAT2 gene and the presbycusis
and tinnitus in a population of Portuguese older adults.
Tinnitus was present in the majority of the presbycusis
individuals.
Age and gender significantly influence the risk for presbycusis
but not for tinnitus. Overall hearing thresholds rates increase
exponentially with age (9% per year), and the increment rate and
speed were gender-specific, but this increasing rate and velocity
are different for women and men.
High blood pressure, thyroid diseases and
hypercholesterolemia seem to have an effect on the hearing
thresholds but no significant associations were found.
Our findings agree with previously observed correlations
between tinnitus, noise exposure, and “high frequency” hearing
loss.
No significant associations between presbycusis, tinnitus, and
GRM7 or NAT2 were found in our sample. Our results precludes
a definitive clarification about the role of GRM7 as a possible
genetic biomarkers for ARHL, although since the genotypes
A/T and T/T have higher odds for HL than A/A genotypes,
thus A allele could be pointed as protective biomarker for HL
Nevertheless, the current state of knowledge regarding GRM7
impact in presbycusis is insufficient to make conclusions, and so,
further large-scale studies are necessary to clarify this relation.
Considering tinnitus severity (according to THI), our results
bring-up very innovative conclusions.
Our data suggests the tracks that can lead to the pathway of a
tinnitus severity biomarker. Potentially individuals carrying the
allele A/T of GRM7 and slow acetylator phenotype of NAT2 (the
later one with smaller statistic relevance) are prone to develop a
more severe form of tinnitus, that requires specific therapeutic
interventions and ideally personally tailored.
The occurrence of presbycusis is thought to be determined
by genetic factors but can also be influenced by environmental
or comorbidities effects, with a huge impact on quality of life
and general health (Huang and Tang, 2010; Ciorba et al., 2015).
However, there is still much research to explore and elucidate
which risk factors contribute more to presbycusis and tinnitus,
so this could help on therapeutic or preventive interventions
(Huang and Tang, 2010).
Information on family history and clinical epidemiological
data may help the design and development of future clinical
management plans for an increasing presbycusis population.
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